Liu-Shen-Wan (LSW), a famous
traditional Chinese medicine for treatment of upper respiratory tract
inflammation, was evaluated for its anti-inflammatory and
analgesic activities.
Acetic acid-elevated vascular permeability,
carboxymethylcellulose sodium (CMC-Na)-induced leukocyte migration and ear
edema induced by
picryl chloride were used to test anti-inflammatory activity. Moreover,
acetic acid-induced writhing and hot-plate tests were used to determine
analgesic effect. It was observed that LSW exerted significant anti-inflammatory and
analgesic activities in these models at doses of 30 and 90mg/kg crude
drug in vivo. In addition, LSW potently inhibited proliferation of human peripheral blood mononuclear cell (PBMC) stimulated by
streptococcal pyrogenic exotoxin at doses of 0.5-5microg/ml in vitro. LSW was then partitioned with
chloroform,
methanol, water and
mineral fraction. Several fractions inhibited
inflammation and
pain in varying degrees. Among them,
chloroform fraction was the most active in hot-plate and writhing tests, and exerted the remarkable inhibitory effect on human PBMC proliferation.
Methanol and water fractions had more suppressive activities in vascular permeability, leukocyte migration and PC-DTH tests. These results suggest that LSW has significantly anti-inflammatory and
analgesic activities. The
chloroform fraction is a key fraction of LSW to the overall anti-inflammatory and
analgesic effects, while
methanol and water fractions also partly contribute to anti-inflammatory activities of LSW.